Addiction

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

JACKSON CENTER, PA / ACCESSWIRE / January 11, 2024 / Halberd Corporation (OTC PINK:HALB) made significant advances in its technology…

2 years ago

Nexalin Technology Unveils Next-Generation HALO™ Clarity

HALO™ Clarity headset Photo: HALO™ Clarity headset A new neurostimulation device to combat the growing global mental health epidemic Designed…

2 years ago

CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Correction: The initial release stated Mr. Peter Croden was previously Global President of Upjohn/Pfizer Animal Health Division in Germany. The…

2 years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

2 years ago

Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Athena will employ its successful history of securing government contracts, spearheading such initiativesJACKSON CENTER, PA / ACCESSWIRE / January 9,…

2 years ago

BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President

ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

2 years ago

Recovery Delivered Expands Services to Accept Medicaid in Ohio for Online Suboxone to Treat Opioid Addiction

Seeing a Suboxone doctor in Ohio just became much more affordable. Patients can now use their Ohio Medicaid to cover…

2 years ago

Clearview Treatment Programs Certified by PsychArmor as a ‘Veteran Ready’ Organization

BRENTWOOD, TN / ACCESSWIRE / January 4, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and…

2 years ago

Introducing PillSafe(R), the New ‘Smart’ Pill Bottle for Prescription Medication

PillSafe® protects the patient with a patented, innovative pill distribution control system that improves dosage safety, prevents prescription drug misuse,…

2 years ago

NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University

Scorpius subsidiary to manufacture novel biologic targeting substance use disorderDURHAM, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE…

2 years ago